kConFab Letter of Intent Submissions
DateInvestigatorsAffiliationProject Title
September 2009, due March 2010
pilot application
Stephen Fox & Gillian Mitchell Peter MacCallum Cancer Centre, Melbourne The identification of BRCA germline mutations using immunhistochemistry
September 2009, due March 2010
full application
Sunil Lakhani Royal Brisbane Hospital, Brisbane Expression of CT-X antigens in familial breast cancer
Nov 2009 Due May 2010
Full Application
Paul James, Gillian Mitchell, Alison Trainer, Judy Kirk, John Hopper; Melissa Southey, Stephen Fox, Ian Campbell Peter MacCallum Cancer Centre, University of Melbourne, Westmead Hopital Sydney Focus on pancreatic cancer
December 2009, due June 2010
Full application
Melissa Southey & David Goldgar The University of Melbourne & The Utah University, USA Breast Cancer Susceptibility Gene Discovery through targeted and whole exome sequencing in High-risk BCFR families.
February 2010
Pilot application
Ashok Venkitaraman et al Hutchison/MRC Research Centre, University of Cambridge, UK Germline BRCA2 mutation carriers are at an increased risk of pancreatic ductal adenocarninoma.
March 2010
Full Application
Stuart MacGregor QIMR, Royal Brisbane Hospital, Brisbane Identifying markers of risk and outcome in ovarian and breast cancer via efficient evaluation of epigenetic changes in non-cancerous tissue.
March 2010, due September 2010
Full Application
John Hopper, Kelly Phillips et al The University of Melbourne & The Peter MacCallum Cancer Centre, Melbourne Statistical analysis of an international 10 year prospective family study of gene-environment interactions on risk of female breast cancer.
May 2010
Full Project due November 2010
Alison Trainer, Paul James, Gillian Mitchell, James Dowty, John Hopper Peter MacCallum Cancer Centre and The University of Melbourne Male Breast Cancer
April, due October 2010
Full Application
James Flanagan Imperial College, London Identification of novel breast cancer subgroups by DNA methylation
June 2010, due December 2010
Full application
Jonathan Beesley, Roger Reddel, Sharon Johnatty, Hilda Pickett Queensland Institute of Medical Research & Children's Medical Research Institute, NSW The TERT locus as a susceptibility gene for ovarian and breast cancer: genetic and functional evaluation
June 2010, due December 2010
Full Project
Sally Hunter, Ian Campbell, Anna DeFazio Peter MacCallum Cancer Centre, Melbourne, Westmead Hospital, Sydney High resolution genome-wide SNP and copy number analysis of genetic
June 2010, due December 2010
Full application
Georgia Chenevix-Trench, Kum Kum Khanna, David Goldgar, Emma Whitelaw & Nick Hayward QIMR, Royal Brisbane Hospital, Brisbane Mutations in genes that modify epigenetic silencing in familial breast cancer
July 2010, due January 2011
Full application
Kum Kum Khanna, Georgia Trench, Sunil Lakhani QIMR, Royal Brisbane Hospital, Brisbane Immunohistochemcial analysis of DNA damage repair proteins in familial breast cancers.
July 2010, due January 2011
Full application
Kelly Bolton and Stephen Chanock National Cancer Institute USA & Cambridge University, UK Detecting Rare Variants for Ovarian Cancer in the 19p13 region.
July 2010, due January 2011
Full Application
Steve Linke Prelude, Inc USA DCIS clinicopathologic characteristics.

A pilot or full application must be made within 6 months of submitting the letter of intent. If more than six months has elapsed, a new letter of intent must be submitted prior to the full application.